Companies: 10,795·Total market cap: $144.5T
Amylyx Pharmaceuticals, Inc.

Amylyx Pharmaceuticals, Inc.

AMLXNASDAQHealthcare● Active
$13.32
$-0.99(-6.92%)
Market Cap$1.1B
P/E Ratio
52W High$18.605
52W Low$4.76
Overview

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · AMLX · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-1.48amlx eps ttm · amlx earnings per shareEarnings history
PE Ratio (TTM)amlx pe ratio ttm · amlx price to earningsPE Ratio deep dive
Revenue (TTM)0.00amlx revenue ttm · amlx annual revenueFull revenue history
Dividend Yield5.64%does amlx pay dividends · amlx dividend yieldDividend history
Shares Outstanding94.6Mamlx shares outstanding · amlx floatShares outstanding history
Next EarningsAug 6, 2026Est.amlx earnings date · amlx next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00▼ 100.00% YoY
202320242025
amylyx pharmaceuticals, inc. revenue · amlx revenue 2025
FY 2025Net Income-$144.7M▲ +52.03% YoY
202320242025
amylyx pharmaceuticals, inc. net income · amlx profit 2025
FY 2025EPS$-1.53▲ +65.46% YoY
202320242025
amlx eps · amylyx pharmaceuticals, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$150.1MEPS: $-1.48View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy11 analystsis amlx a buy · amlx analyst rating
Strong Buy
0
Buy
10
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$21.00Low
$13.32Current
$24.50Avg Target83.93% upside
$28.00High
amlx price target · amlx 12 month forecast

Total: 11 · Buy rate: 90.9%

The AMLX analyst consensus is Buy, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month price target is $24.50, representing +83.93% upside from the current price of $13.32.

Stock Performance

Full History
1D-6.92%
1W+0.15%
1M-9.57%
3M-3.83%
YTD+10.26%
1Y+144.85%
5Y-26.29%

About Amylyx Pharmaceuticals, Inc.

CEOJoshua Cohen
IPO DateJan 7, 2022
Employees123
CountryUS
Websiteamylyx.com

Amylyx Pharmaceuticals, Inc. a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The c…

what is amylyx pharmaceuticals, inc. · amlx stock overview · amylyx pharmaceuticals, inc. company profile · who is amylyx pharmaceuticals, inc. ceo · amlx NASDAQ · amylyx pharmaceuticals, inc. headquarters · amylyx pharmaceuticals, inc. business segments

About Stock Overview & Key Data

Amylyx Pharmaceuticals, Inc. (AMLX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 7, 2022. As of the latest trading session, AMLX stock price is $13.32, with a market capitalization of $1.1B. The stock has returned +144.85% over the past 12 months and +10.26% year-to-date.

According to 11 Wall Street analysts, the consensus rating for Amylyx Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $24.50. In fiscal year 2025, Amylyx Pharmaceuticals, Inc. reported revenue of — and net income of -$144.7M. For detailed data — including Amylyx Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Amylyx Pharmaceuticals, Inc. (AMLX) stock price is $13.32. The stock is traded on NASDAQ under the ticker symbol AMLX. The 52-week range is $4.76 – $18.61.

AMLX stock priceAMLX quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice